Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 31/5/2020
SIETES contiene 93020 citas

 
 
<< anterior 21 a 40 de 341 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]
22.Enlace a cita original Cita con resumen
Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol 2011;72:381-93. [Ref.ID 90989]
24.Tiene citas relacionadas Cita con resumen
Liang X-F, Liu D-W, Li K-L, Wu WD, Zhu BP, Wang HQ, Luo H-M, Cao L-S, Zheng JS, Yin DP, Cao L, Wu BB, Bao H-H, Xu DS, Yang WZ, Wang Y. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011;364:638-47. [Ref.ID 90215]
25.Enlace a cita original Cita con resumen
Van Den Eeden SK, Tanner C, Albers K, Shan J, Nelson L, Quesenberry C. Amphetamine use and risk of Parkinson's disease in a prospective study. Medpage 2011:20 febrero. [Ref.ID 90031]
26. Cita con resumen
López Nieto M, Gómez Garrido J, Losa Palacios A, Águila Manso G. Síndrome de Guillain-Barré secundario a vacunación de gripe H1N1. Rev Clin Esp 2010;210:485-6. [Ref.ID 89222]
27. Cita con resumen
Prothro C, Kudish K, Fiellin M, Meek J, Tellman N, Milewski M, Hogan B, Holtzman C, Danila R, Dunning L, Lynfield R, Scherzinger K, Connor W, Baumbach J, Giambrone GP, Zansky SM, Smith PF, Thomas A, Mosites E, Kirschke D, Viray M, Lewis P, Sejvar J, Baughman A, Vellozzi C, Fridkin S, Conner S, Morgan O, Lu P, Furlow C, Singleton JA, Hale CR, Kattan J, Murphree R, Oh JY, Wise M. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine --- United States, 2009--2010. MMWR Morb Mortal Wkly Rep 2010;59:1-5. [Ref.ID 88533]
28.Tiene citas relacionadas Cita con resumen
Huang WT, Chuang J-H, Kuo SH-S. Monitoring the safety of pandemic H1N1 vaccine. Lancet 2010;375:1164. [Ref.ID 88235]
29.Tiene citas relacionadas Cita con resumen
DeStefano F, Tokars J. H1N1 vaccine safety monitoring: beyond background rates. Lancet 2010;375:1146-7. [Ref.ID 88231]
31. Cita con resumen
Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009;374:2115-22. [Ref.ID 87323]
32. Cita con resumen
33. Cita con resumen
Anónimo. Human papillomavirus (HPV) immunisation programme—first year safety review. Drug Safety Update 2009;3:5-8. [Ref.ID 86741]
34.Tiene citas relacionadas Cita con resumen
Haug C. The risks and benefits of HPV vaccination. JAMA 2009;302:795-6. [Ref.ID 86576]
35.Tiene citas relacionadas Cita con resumen
Neuzil KM. Pandemic influenza vaccine policy - Considering the early evidence. N Engl J Med 2009;361:59. [Ref.ID 86540]
36. Cita con resumen
Anónimo. Supply and safety issues surrounding an H1N1 vaccine. Lancet 2009;374:358. [Ref.ID 86401]
37. Cita con resumen
Platt R, Wilson M, Chan A, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network — Improving the evidence of medical-product safety . N Engl J Med 2009;361:645-7. [Ref.ID 86387]
38. Cita con resumen
Anónimo. Colorants alimentaires et symptômes d'hyperactivité chez des enfants. Prescrire 2009;29:433. [Ref.ID 86023]
39. Cita con resumen
Anónimo. Métoclopramide: dyskinésies tardives. Prescrire 2009;29:432. [Ref.ID 86019]
40.Tiene citas relacionadas Cita con resumen
Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, Ritchie DL, Dabaghian R, Ambrose HE, Gill ON. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338:1316. [Ref.ID 85943]
Seleccionar todas
 
<< anterior 21 a 40 de 341 siguiente >>